128 related articles for article (PubMed ID: 14550749)
1. Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis.
Coulson M; Gibson GG; Plant N; Hammond T; Graham M
Toxicol Appl Pharmacol; 2003 Oct; 192(2):154-63. PubMed ID: 14550749
[TBL] [Abstract][Full Text] [Related]
2. Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole.
Fort FL; Miyajima H; Ando T; Suzuki T; Yamamoto M; Hamashima T; Sato S; Kitazaki T; Mahony MC; Hodgen GD
Fundam Appl Toxicol; 1995 Jul; 26(2):191-202. PubMed ID: 7589908
[TBL] [Abstract][Full Text] [Related]
3. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
Masubuchi N; Hakusui H; Okazaki O
Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
[TBL] [Abstract][Full Text] [Related]
4. Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer.
de Peyster A; MacLean KJ; Stephens BA; Ahern LD; Westover CM; Rozenshteyn D
Toxicol Sci; 2003 Mar; 72(1):31-42. PubMed ID: 12604832
[TBL] [Abstract][Full Text] [Related]
5. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans.
Cook JC; Klinefelter GR; Hardisty JF; Sharpe RM; Foster PM
Crit Rev Toxicol; 1999 Mar; 29(2):169-261. PubMed ID: 10213111
[TBL] [Abstract][Full Text] [Related]
6. Pronamide: Human relevance of liver-mediated rat leydig cell tumors.
Rasoulpour RJ; Andrus AK; Marty MS; Zhang F; Thomas J; LeBaron MJ; Papineni S; Pottenger LH; Eisenbrandt DL
Regul Toxicol Pharmacol; 2015 Jul; 72(2):394-404. PubMed ID: 25846364
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
8. 7,12-Dimethylbenz[a]anthracene inhibition of steroid production in MA-10 mouse Leydig tumor cells is not directly linked to induction of CYP1B1.
Mandal PK; McDaniel LR; Prough RA; Clark BJ
Toxicol Appl Pharmacol; 2001 Sep; 175(3):200-8. PubMed ID: 11559018
[TBL] [Abstract][Full Text] [Related]
9. Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone.
Murakami M; Hosokawa S; Yamada T; Harakawa M; Ito M; Koyama Y; Kimura J; Yoshitake A; Yamada H
Toxicol Appl Pharmacol; 1995 Apr; 131(2):244-52. PubMed ID: 7716766
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors.
Masubuchi N; Okazaki O
Chem Biol Interact; 1997 Nov; 107(1-2):63-74. PubMed ID: 9402950
[TBL] [Abstract][Full Text] [Related]
12. Alteration of follicle-stimulating hormone and testosterone regulation of messenger ribonucleic acid for Sertoli cell proteins in the rat during the acute phase of spinal cord injury.
Ottenweller JE; Li MT; Giglio W; Anesetti R; Pogach LM; Huang HF
Biol Reprod; 2000 Sep; 63(3):730-5. PubMed ID: 10952914
[TBL] [Abstract][Full Text] [Related]
13. Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
Masubuchi N; Hakusui H; Okazaki O
Drug Metab Dispos; 1997 May; 25(5):584-9. PubMed ID: 9152597
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
[TBL] [Abstract][Full Text] [Related]
15. Role of testicular interstitial macrophages in regulating testosterone release in hyperprolactinemia.
Huang WJ; Yeh JY; Kan SF; Chang LS; Wang PS
J Cell Biochem; 2003 Mar; 88(4):766-73. PubMed ID: 12577310
[TBL] [Abstract][Full Text] [Related]
16. Safety and pharmacokinetics of oral lansoprazole in preadolescent rats exposed from weaning through sexual maturity.
Youssef AF; Turck P; Fort FL
Reprod Toxicol; 2003; 17(1):109-16. PubMed ID: 12507665
[TBL] [Abstract][Full Text] [Related]
17. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
[TBL] [Abstract][Full Text] [Related]
18. Suppression of male-specific cytochrome P450 2c and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl in rat liver is not causally related to changes in serum testosterone.
Yeowell HN; Waxman DJ; LeBlanc GA; Linko P; Goldstein JA
Arch Biochem Biophys; 1989 Jun; 271(2):508-14. PubMed ID: 2499261
[TBL] [Abstract][Full Text] [Related]
19. Leydig cell tumor of the testis: analysis of testosterone production and secretion by three-dimensional histoculture.
Sasano H; Maehara I; Ueno J; Orikasa S; Nagura H
Endocr J; 1996 Feb; 43(1):73-8. PubMed ID: 8732455
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of reappearance of luteinizing hormone receptor expression and function in rat testis after selective Leydig cell destruction by ethylene dimethane sulfonate.
Tena-Sempere M; Rannikko A; Kero J; Zhang FP; Huhtaniemi IT
Endocrinology; 1997 Aug; 138(8):3340-8. PubMed ID: 9231786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
